论文部分内容阅读
新生儿致病性埃希氏大肠杆菌性腹泻是新生儿常见疾病之一,我院一向用口服新霉素治疗,因抗药性和副作用的出现,为选择更有效的抗菌药物,我们于1983年1～8月对我院新生儿病区收治致病性埃希氏大肠杆菌性腹泻98例,随机地采用不同的抗菌药物进行治疗,现将疗效报告如下。一、病例选择标准 1.新生儿病区内同期有致病性埃希氏大肠杆菌O_(119)或O_(86)腹泻散发病例。 2.突然发病,腹泻1日5次以上,黄色或黄绿色稀水样便。 3.排除喂养失调性、肠道外感染性及肠道内病毒性腹泻。
Neonatal pathogenic Escherichia coli diarrhea is one of the common neonatal diseases, our hospital has always been treated with oral neomycin, because of the emergence of drug resistance and side effects, in order to choose more effective antibacterial drugs, we in 1983 From January to August, 98 cases of pathogenic Escherichia coli diarrhea were admitted to the newborn ward of our hospital, and different antimicrobial agents were randomly used for treatment. The curative effect is reported as follows. First, the selection criteria of cases 1. Neonatal ward during the same period there pathogenic Escherichia coli O_ (119) or O_ (86) diarrhea sporadic cases. Sudden onset, diarrhea, 5 times more than 1, yellow or yellow-green watery stools. 3. To exclude feeding disorders, intestinal infectivity and intestinal viral diarrhea.